PMA P150013S015

Device
PD-L1 IHC 22C3 PharmDx
Applicant
Agilent Technologies, Inc.
PMA number
P150013
Supplement
S015
Product code
PLS
Decision date
2019-03-13
Classification
Immunohistochemistry Assay, Antibody, Programmed Death-ligand 1
Generic name
Immunohistochemistry assay, antibody, programmed death-ligand 1
Approval order statement
Addition of a distribution site.

Current openFDA PMA Record#

Device
PD-L1 IHC 22C3 PharmDx
Applicant
Agilent Technologies, Inc.
PMA number
P150013
Supplement
S015
Product code
PLS
Generic name
Immunohistochemistry assay, antibody, programmed death-ligand 1
Decision date
2019-03-13
Decision code
OK30
Date received
2019-02-15
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Addition of a distribution site.